Ociperlimab represents a significant breakthrough in addressing self-immune disorders. The new antibody therapy blocks neonatal-associated Fc receptor gamma-chain, the protein implicated in https://ociperlimab-humanized-ig883483.blogdigy.com/ociperlimab-this-novel-approach-in-immune-mediated-illness-68254810